← Issue №12/ week of Sep 20, 2026/Hepatology

Alcohol consumption increases risk of hepatocellular carcinoma in chronic hepatitis B patients.

From GI Signals issue №12: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

Hepatology prospective cohort · n=1,010 · Sep 18, 2026 · Clin Gastro Hep · IF 16.2

Alcohol consumption increases risk of hepatocellular carcinoma in chronic hepatitis B patients.

New evidencehepatocellular carcinomaviral hepatitisalcohol-associated liver diseaseepidemiology
Clinical takeawayCounsel CHB patients, regardless of cirrhosis status, to abstain from alcohol or reduce intake to <140/210 g/week to lower HCC risk, especially in those with high alcohol consumption (>350/420 g/week), which quadruples HCC risk (aHR 4.00, P<0.001).
What it foundEach 100 g/week increase in alcohol intake raised HCC risk by 33% (aHR 1.33, P<0.001), and high alcohol intake (>350/420 g/week) quadrupled HCC risk (aHR 4.00, P<0.001) in CHB patients.
ContextConfirms and quantifies the synergistic risk of alcohol and CHB for HCC, extending prior evidence by showing consistent risk across cirrhotic and non-cirrhotic subgroups.
No standard claimed for this paper

Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.

Chen Y … Nan Y · Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association · IF 16.2 · PubMed ↗Permalink
← Read the whole of issue №12 Every paper GI Signals surfaces gets a page like this one. All issues